AKASA vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
AKASA is the leading generative AI platform for healthcare revenue cycle management; #1 RCM startup 2025 (Black Book); Cleveland Clinic strategic partnership; removes 71% of claims from staff queues.
About
AKASA is a healthcare technology company applying generative AI to automate and optimize revenue cycle management (RCM) for hospitals and health systems across the United States. Founded in 2018 and headquartered in San Francisco, AKASA's platform is trained on each health system's own clinical and financial data, enabling AI that understands the specific nuances of individual organizations' billing workflows, payer rules, and coding patterns. The company automates critical revenue cycle processes including prior authorization, medical coding, claim status retrieval, and denial management — reducing manual work, accelerating cash collections, and decreasing operational costs without requiring health systems to replace existing EHR or billing systems.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.